Additionally, in mast cells, luteolin has been shown to have an inhibitory effect on FcεRI-mediated mast cell degranulation and MAS-related G protein-coupled receptor-X2 (MRGPRX2)-mediated mast cell activation also termed a pseudo-allergic reaction. Here, FCER1A is linked to allergic disease.